The vaccine, developed by the University of Oxford, also triggers lower adverse responses among the elderly, British drug maker AstraZeneca Plc AZN.L, which is helping manufacture the vaccine, said on Monday.
Read more at:
Vaccine hopes rise as Oxford jab prompts immune response among old as well as young adults | Reuters